Keeping up with new plant announcements, expansion plans, and brand new companies is a great way to find out about the latest opportunities within your commutable area. But it can also be prohibitively time-consuming.
So we’ve decided to give you all the benefits with none of the time-draining difficulties!
In this post, we’re keeping an active (and regularly updated) record of announcements made by companies within the UK’s pharmaceutical and medical device industries. And, as always, our focus is on manufacturing sites.
BTW, if you are interested in a career in pharmaceutical manufacturing, check out our University Certificate in Pharmaceutical and Medicinal Product Manufacturing
- GSK (Hertfordshire) – announced plans to expand their Stevenage site to form a new UK hub that will create up to 5,000 new jobs over the next 5-10 years
- Thornton & Ross (West Yorkshire) – created 100 new jobs in Huddersfield with support from Leeds City Region Enterprise Partnership
- Piramal Pharma (Stirlingshire) – applied for permission to extend their Grangemouth site, that would lead to the creation of 70 new roles
Despite a difficult year for many industries, the UK’s pharma and med device manufacturing industries continued to thrive. Here’s a run down of the announcements from throughout the year:
- PCI Pharma Services (Gwent) – gained approval for a site expansion that includes a new packaging building, which will bring 50-100 new jobs to the area
- Randox (Antrim) – announced the recruitment of 200 new staff in May, to help support the COVID-19 testing capabilities.
- Thermo Fisher Scientific (Perthshire) – began an expansion to ramp up production to support the manufacture of COVID-19 test tubes, with 200 new roles created
- Thermo Fisher Scientific (Wiltshire) – are expanding their Swindon site with the creation of 200 new jobs
- Valneva (West Lothian) – announced the creation of 75 new jobs as the site expanded to support COVID-19 vaccine manufacture
The UK Government also announced the new Medicines and Diagnostic Manufacturing Transformation Fund – a £20m fund designed to support the improvement of medicine supply chains within the UK and “create thousands of jobs“.
- Almac (Lothian) – are doubling their Edinburgh facility footprint to scale up personalised cancer vaccine activities
- Catalent (Wiltshire) – announced the creation of 100 new jobs as a result of £20m investment to boost production capabilities
- Lonza (Berkshire) – are expanding their Slough site which is expected to lead to 180 new jobs
- Pfizer (Kent) – invested £5m in the Discovery Park in Sandwich to grow its development and manufacture of paediatric medicines at the site
Post Your Comments Below